- Home
- RDY vs DOCS Comparison
RDY vs DOCS Comparison
Compare RDY & DOCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDY
- DOCS
- Stock Information
- Founded
- RDY 1984
- DOCS 2010
- Country
- RDY India
- DOCS United States
- Employees
- RDY N/A
- DOCS N/A
- Industry
- RDY Biotechnology: Pharmaceutical Preparations
- DOCS Retail: Computer Software & Peripheral Equipment
- Sector
- RDY Health Care
- DOCS Technology
- Exchange
- RDY Nasdaq
- DOCS Nasdaq
- Market Cap
- RDY 11.8B
- DOCS 10.9B
- IPO Year
- RDY N/A
- DOCS 2021
- Fundamental
- Price
- RDY $14.12
- DOCS $66.98
- Analyst Decision
- RDY Strong Buy
- DOCS Buy
- Analyst Count
- RDY 2
- DOCS 19
- Target Price
- RDY $16.95
- DOCS $66.74
- AVG Volume (30 Days)
- RDY 962.0K
- DOCS 1.7M
- Earning Date
- RDY 07-23-2025
- DOCS 08-07-2025
- Dividend Yield
- RDY 0.51%
- DOCS N/A
- EPS Growth
- RDY 2.20
- DOCS 45.79
- EPS
- RDY 0.79
- DOCS 1.17
- Revenue
- RDY $3,897,394,052.00
- DOCS $589,636,000.00
- Revenue This Year
- RDY $7.33
- DOCS $13.33
- Revenue Next Year
- RDY $1.96
- DOCS $10.90
- P/E Ratio
- RDY $17.94
- DOCS $57.30
- Revenue Growth
- RDY 15.86
- DOCS 19.45
- 52 Week Low
- RDY $12.26
- DOCS $35.32
- 52 Week High
- RDY $16.41
- DOCS $85.21
- Technical
- Relative Strength Index (RSI)
- RDY 45.65
- DOCS 58.87
- Support Level
- RDY $14.08
- DOCS $66.11
- Resistance Level
- RDY $14.32
- DOCS $69.80
- Average True Range (ATR)
- RDY 0.18
- DOCS 2.05
- MACD
- RDY 0.03
- DOCS 0.24
- Stochastic Oscillator
- RDY 10.38
- DOCS 64.42
About RDY Dr. Reddy's Laboratories Ltd
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
About DOCS Doximity Inc.
Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.